Could new syphilis tests speed up diagnosis?

NCT ID NCT07089836

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing two new blood test kits designed to diagnose syphilis. Researchers will collect blood samples from 1000 people, including those with symptoms, those at high risk, and healthy controls. The goal is to see how accurate these new kits are compared to standard lab tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ALPCO Syphilis-T and Syphilis-NT CLIA kits (diagnostic devices)
What this could lead to
If successful, these kits could provide a faster, automated way to diagnose syphilis, improving detection and treatment.
What could go wrong
This is a diagnostic accuracy study, not a treatment trial. The kits may not perform as well as expected, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOODDRAW are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Chemidox Clinical Trials California

    RECRUITING

    Lancaster, California, 93534, United States

  • Chemidox Tx LLC

    RECRUITING

    Houston, Texas, 77071, United States

  • Folio Clinical Research

    RECRUITING

    Los Angeles, California, 90036, United States

  • IMA Clinical Research - St.Petersburg

    RECRUITING

    St. Petersburg, Florida, 33704, United States

  • Segel Trials

    RECRUITING

    North Miami, Florida, 33161, United States

  • VAST Clinical Research

    RECRUITING

    Mesquite, Texas, 75149, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.